SurModics (SRDX) Tops Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. NVDA
5. OPCH
6. BBIO
7. GOOGL
8. AMD
9. CHRW
10. SKYD

Go back to SurModics (SRDX) Tops Q3 EPS by 5c

SurModics Reports Third Quarter Fiscal 2015 Results

August 5, 2015 7:30 AM EDT

GAAP Revenue Growth of 9% to $15.9 Million and GAAP EPS of $0.30 versus $0.26 Medical Device Business Revenue up 8%; IVD up 13% Continued Progress Developing Our Drug Coated Balloon Platform Raises Fiscal 2015 Revenue and EPS Guidance

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2015 third quarter, ended June 30, 2015.

According to SurModics President... More